|
Volumn 20, Issue 11, 2006, Pages 1024-1030
|
Anticancer effect of three pyrazole derivatives
|
Author keywords
Anticancer activity; bdpma: N,N bis (3,5 dimethylpyrazol 1 yl)methyl aniline (1); Cytotoxicity; In vitro; Pyrazole; tdpmpp: N,N,N , N tetrakis (3,5 dimethylpyrazol 1 yl)methyl para phenylenediamine (2); tdpmppd: N,N,N , N tetrakis (1,5 dimethylpyrazol 3 yl)methyl para phenylenediamine (3); Tripod
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTOTOXIC AGENT;
DOXORUBICIN;
N,N BIS[(3,5 DIMETHYLPYRAZOL 1 YL)METHYL]ANILINE;
N,N,N',N' TETRAKIS[(1,5 DIMETHYLPYRAZOL 3 YL)METHYL] 4 PHENYLENEDIAMINE;
N,N,N',N' TETRAKIS[(3,5 DIMETHYLPYRAZOL 1 YL)METHYL] 4 PHENYLENEDIAMINE;
PYRAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
ANALYSIS OF VARIANCE;
ANIMAL CELL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CARBON NUCLEAR MAGNETIC RESONANCE;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG PURIFICATION;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IC 50;
IN VITRO STUDY;
MOUSE;
NONHUMAN;
PROTON NUCLEAR MAGNETIC RESONANCE;
SPECTROSCOPY;
TUMOR CELL LINE;
ANILINE COMPOUNDS;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
HUMANS;
MOLECULAR STRUCTURE;
PHENYLENEDIAMINES;
PYRAZOLES;
|
EID: 33750002699
PISSN: 14786419
EISSN: 14786427
Source Type: Journal
DOI: 10.1080/14786410600921441 Document Type: Article |
Times cited : (120)
|
References (25)
|